Personalized T Cell-Directed Cancer Immunotherapy Endeavor Award (2023-Present) Dana-Farber Cancer Institute: Catherine Wu, MD • The Broad Institute: Nir Hacohen, PhD; Fei Chen, PhD Read More
Inflammatory Drivers of The Obesity-Cancer Connection Endeavor Award (2023-Present) Vanderbilt University: Jeffrey Rathmell, PhD; Alyssa Hasty, PhD • The University of Pennsylvania: Kathryn Wellen, PhD • University of Tennessee Health Sciences Center: Liza Makowski, PhD Read More
Harnessing Senescence Biology for Immune Oncology Endeavor Award (2023-Present) Memorial Sloan Kettering Cancer Center: Scott Lowe, PhD; Paul Romesser, MD; Michel Sadelain, MD, PhD; Julio Garcia-Aguilar, MD; Andrea Schietinger, PhD; Dana Pe’er, PhD Read More
Engineering Multimodal Immunotherapies against Small-Cell Neuroendocrine Tumors Endeavor Award (2023-Present) Stanford University: Julien Sage, PhD; K. Christopher Garcia, PhD; Crystal Mackall, MD; Rogelio Hernández-López, PhD Read More
IMMUNESCAPE – Dissecting the Impact of Clonal Evolutionary Dynamics on Tumor Immunogenicity IN PARTNERSHIP WITH THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH AND THE PEZCOLLER FOUNDATION (2023-PRESENT) Isidro Cortés-Ciriano, PhD, EMBL-European Bioinformatics Institute Read More
Investigating Novel KRAS Inhibitors Effects on the Tumor-Immune Responses and Integration of KRAS Inhibition with Immune Based Therapies ASPIRE Award (2023-Present) Taha Merghoub, PhD; Jedd Wolchok, MD, PhD, Weill Medical College of Cornell University Read More